300452 山河药辅
已收盘 11-20 15:00:00
资讯
新帖
简况
山河药辅(300452)2024年三季报简析:增收不增利,盈利能力上升
证券之星 · 10-24
山河药辅(300452)2024年三季报简析:增收不增利,盈利能力上升
图解山河药辅三季报:第三季度单季净利润同比减23.60%
证券之星 · 10-23
图解山河药辅三季报:第三季度单季净利润同比减23.60%
山河药辅最新公告:第三季度净利润2689.28万元 同比下降23.60%
证券之星 · 10-22
山河药辅最新公告:第三季度净利润2689.28万元 同比下降23.60%
山河药辅(300452.SZ)发布前三季度业绩,净利润1.22亿元,下降0.89%
智通财经 · 10-22
山河药辅(300452.SZ)发布前三季度业绩,净利润1.22亿元,下降0.89%
V观财报|山河药辅生产基地安全事故致一死,具体原因尚在调查
中新经纬 · 10-21
V观财报|山河药辅生产基地安全事故致一死,具体原因尚在调查
山河药辅(300452.SZ):发生安全事故 造成一名员工死亡
智通财经网 · 10-21
山河药辅(300452.SZ):发生安全事故 造成一名员工死亡
山河药辅(300452)10月14日主力资金净卖出195.57万元
证券之星 · 10-14
山河药辅(300452)10月14日主力资金净卖出195.57万元
10月8日山河药辅发布公告,其股东减持232.6万股
证券之星 · 10-08
10月8日山河药辅发布公告,其股东减持232.6万股
山河药辅(300452.SZ)股东复星医药累计减持282.63万股
智通财经 · 10-08
山河药辅(300452.SZ)股东复星医药累计减持282.63万股
山河药辅(300452.SZ)发布上半年业绩,净利润9553.3万元,增长8.16%
智通财经 · 08-27
山河药辅(300452.SZ)发布上半年业绩,净利润9553.3万元,增长8.16%
山河药辅最新公告:上半年净利润同比增长8.16%
证券之星 · 08-27
山河药辅最新公告:上半年净利润同比增长8.16%
山河药辅:公司定期报告和公司网站均有公司的联系方式和电话,欢迎洽谈合作
证券之星 · 08-08
山河药辅:公司定期报告和公司网站均有公司的联系方式和电话,欢迎洽谈合作
山河药辅最新公告:新增1种药用辅料产品聚维酮K25
证券之星 · 08-06
山河药辅最新公告:新增1种药用辅料产品聚维酮K25
【山河药辅(300452.SZ):聚维酮K25获CDE登记号】智通财经APP讯,山河药辅(300452.SZ)发布公告,近日公司新增1种药用辅料产品:聚维酮K25获得国家药品监督管理局药品审评中心(简称“CDE”)的登记号,为F20240000334。
智通财经 · 08-06
【山河药辅(300452.SZ):聚维酮K25获CDE登记号】智通财经APP讯,山河药辅(300452.SZ)发布公告,近日公司新增1种药用辅料产品:聚维酮K25获得国家药品监督管理局药品审评中心(简称“CDE”)的登记号,为F20240000334。
山河药辅(300452.SZ):聚维酮K25获CDE登记号
智通财经网 · 08-06
山河药辅(300452.SZ):聚维酮K25获CDE登记号
山河药辅最新公告:公司新增1种药用辅料产品
证券之星 · 07-11
山河药辅最新公告:公司新增1种药用辅料产品
山河药辅(300452)7月1日主力资金净卖出610.28万元
证券之星 · 07-01
山河药辅(300452)7月1日主力资金净卖出610.28万元
山河药辅:复星医药拟减持1%公司股份
证券之星 · 06-28
山河药辅:复星医药拟减持1%公司股份
山河药辅:复星医药拟减持1%公司股份山河药辅公告,持有公司11.20%股份的股东复星医药因经营需要,计划在2024年7月22日至2024年10月20日期间,通过集中竞价方式减持不超过232.
格隆汇 · 06-28
山河药辅:复星医药拟减持1%公司股份山河药辅公告,持有公司11.20%股份的股东复星医药因经营需要,计划在2024年7月22日至2024年10月20日期间,通过集中竞价方式减持不超过232.
山河药辅:公司生产和经营现金流一直以来确实都比较好,每年的分红比例也较高
证券之星 · 06-27
山河药辅:公司生产和经营现金流一直以来确实都比较好,每年的分红比例也较高
加载更多
公司概况
公司名称:
安徽山河药用辅料股份有限公司
所属行业:
医药制造业
上市日期:
2015-05-15
主营业务:
安徽山河药用辅料股份有限公司的主营业务为药用辅料的研发、生产和销售。公司主要产品涵盖填充剂、黏合剂、崩解剂、润滑剂、包衣材料等常用口服固体制剂类药用辅料和注射级药用辅料等。其中:微晶纤维素、羟丙甲纤维素、低取代羟丙纤维素、羧甲淀粉钠、硬脂酸镁和薄膜包衣粉先后被评定为安徽省高新技术产品,“立崩”牌羧甲淀粉钠先后获得淮南市知名产品、安徽省名牌产品和“中国化学制药行业药用辅料优秀产品品牌”、首批“安徽工业精品”称号,羟丙甲纤维素荣获“中国化学制药行业优秀产品品牌”奖。微晶纤维素、硬脂酸镁和薄膜包衣粉产品被评定为淮南市知名产品,并有多个产品列入《中国高新技术产品出口目录》。公司多次获得“中国化学行业药用辅料优秀企业品牌”称号。
发行价格:
14.96
{"stockData":{"symbol":"300452","market":"SZ","secType":"STK","nameCN":"山河药辅","latestPrice":12.83,"timestamp":1732086192000,"preClose":12.64,"halted":0,"volume":4248459,"delay":0,"floatShares":187000000,"shares":234000000,"eps":0.6843,"marketStatus":"已收盘","marketStatusCode":5,"change":0.19,"latestTime":"11-20 15:00:00","open":12.55,"high":12.83,"low":12.54,"amount":54114600,"amplitude":0.0229,"askPrice":12.83,"askSize":396,"bidPrice":12.81,"bidSize":21,"shortable":0,"etf":0,"ttmEps":0.6843,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732152600000},"adr":0,"adjPreClose":12.64,"symbolType":"stock","openAndCloseTimeList":[[1732066200000,1732073400000],[1732078800000,1732086000000]],"highLimit":13.9,"lowLimit":11.38,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":234447103,"pbRate":3.39,"roa":"--","roe":"13.81%","epsLYR":0.69,"committee":-0.388188,"marketValue":3008000000,"floatMarketCap":2397000000,"peRate":18.749087,"changeRate":0.015,"turnoverRate":0.0227,"status":0},"requestUrl":"/m/hq/s/300452","defaultTab":"news","newsList":[{"id":"2477059951","title":"山河药辅(300452)2024年三季报简析:增收不增利,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2477059951","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477059951?lang=zh_cn&edition=full","pubTime":"2024-10-24 06:06","pubTimestamp":1729721199,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期山河药辅发布2024年三季报。截至本报告期末,公司营业总收入6.44亿元,同比上升0.62%,归母净利润1.22亿元,同比下降0.89%。本报告期山河药辅盈利能力上升,毛利率同比增幅8.98%,净利率同比增幅17.6%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102400004758.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0177","300452"],"gpt_icon":0},{"id":"2477363940","title":"图解山河药辅三季报:第三季度单季净利润同比减23.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477363940","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477363940?lang=zh_cn&edition=full","pubTime":"2024-10-23 00:32","pubTimestamp":1729614771,"startTime":"0","endTime":"0","summary":"证券之星消息,山河药辅2024年三季报显示,公司主营收入6.44亿元,同比上升0.62%;归母净利润1.22亿元,同比下降0.89%;扣非净利润1.05亿元,同比下降5.12%;其中2024年第三季度,公司单季度主营收入1.94亿元,同比上升3.74%;单季度归母净利润2689.28万元,同比下降23.6%;单季度扣非净利润2494.96万元,同比下降13.05%;负债率37.17%,投资收益1689.81万元,财务费用884.4万元,毛利率32.19%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102300000191.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300452"],"gpt_icon":0},{"id":"2477800325","title":"山河药辅最新公告:第三季度净利润2689.28万元 同比下降23.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477800325","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477800325?lang=zh_cn&edition=full","pubTime":"2024-10-22 17:11","pubTimestamp":1729588287,"startTime":"0","endTime":"0","summary":"山河药辅发布2024年第三季度报告,公司前三季度实现营业收入6.44亿元,同比增长0.62%;净利润1.22亿元,同比下降0.89%。其中,第三季度实现营业收入1.94亿元,同比增长3.74%;净利润2689.28万元,同比下降23.60%。报告期内,公司经营活动产生的现金流量净额为2469.28万元,同比下降47.71%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102200028687.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300452"],"gpt_icon":0},{"id":"2477807139","title":"山河药辅(300452.SZ)发布前三季度业绩,净利润1.22亿元,下降0.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477807139","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477807139?lang=zh_cn&edition=full","pubTime":"2024-10-22 17:01","pubTimestamp":1729587703,"startTime":"0","endTime":"0","summary":"智通财经APP讯,山河药辅(300452.SZ)发布2024年三季度报告,前三季度,公司实现营业收入6.44亿元,同比增长0.62%。归属于上市公司股东的净利润1.22亿元,同比下降0.89%。归属于上市公司股东的扣除非经常性损益的净利润1.05亿元,同比下降5.12%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1197395.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300452"],"gpt_icon":0},{"id":"2477028104","title":"V观财报|山河药辅生产基地安全事故致一死,具体原因尚在调查","url":"https://stock-news.laohu8.com/highlight/detail?id=2477028104","media":"中新经纬","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477028104?lang=zh_cn&edition=full","pubTime":"2024-10-21 08:31","pubTimestamp":1729470692,"startTime":"0","endTime":"0","summary":"山河药辅称,目前,公司整体系列生产基地和车间生产经营秩序正常,经初步预计,本...","market":"sh","thumbnail":"http://www.jwview.com/jingwei/10-21/U820P902T1D609024F10DT20241021083132.jpg","type":0,"news_type":0,"thumbnails":["http://www.jwview.com/jingwei/10-21/U820P902T1D609024F10DT20241021083132.jpg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.jwview.com/jingwei/html/10-21/609024.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zxjw_stock","symbols":["300452"],"gpt_icon":0},{"id":"2477046534","title":"山河药辅(300452.SZ):发生安全事故 造成一名员工死亡","url":"https://stock-news.laohu8.com/highlight/detail?id=2477046534","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477046534?lang=zh_cn&edition=full","pubTime":"2024-10-21 08:04","pubTimestamp":1729469091,"startTime":"0","endTime":"0","summary":"山河药辅(300452.SZ)公告,2024年10月19日14时许,公司“新型药用...","market":"hk","thumbnail":"https://img.zhitongcaijing.com/astock/3.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/3.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1196485.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0239","BK0177","300452"],"gpt_icon":0},{"id":"2475335018","title":"山河药辅(300452)10月14日主力资金净卖出195.57万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475335018","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475335018?lang=zh_cn&edition=full","pubTime":"2024-10-14 15:25","pubTimestamp":1728890707,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年10月14日收盘,山河药辅报收于12.55元,上涨0.48%,换手率2.52%,成交量4.7万手,成交额5837.38万元。10月14日的资金流向数据方面,主力资金净流出195.57万元,占总成交额3.35%,游资资金净流入44.34万元,占总成交额0.76%,散户资金净流入151.23万元,占总成交额2.59%。山河药辅主营业务:药用辅料的研发、生产和销售。该股最近90天内共有1家机构给出评级,买入评级1家;过去90天内机构目标均价为18.15。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101400013059.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0177","BK0239","300452"],"gpt_icon":0},{"id":"2473852475","title":"10月8日山河药辅发布公告,其股东减持232.6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2473852475","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473852475?lang=zh_cn&edition=full","pubTime":"2024-10-08 22:01","pubTimestamp":1728396060,"startTime":"0","endTime":"0","summary":"证券之星消息,10月8日山河药辅发布公告《山河药辅:关于5%以上股东减持股份比例变动达到1%暨减持股份计划实施完毕的公告》,其股东上海复星医药产业发展有限公司于2024年7月31日至2024年10月8日间合计减持232.6万股,占公司目前总股本的0.9922%,变动期间该股股价上涨33.02%,截止10月8日收盘报14.22元。股东增减持详情见下表:根据山河药辅2024年中报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100800038855.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0177","300452","BK0239"],"gpt_icon":0},{"id":"2473013420","title":"山河药辅(300452.SZ)股东复星医药累计减持282.63万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2473013420","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473013420?lang=zh_cn&edition=full","pubTime":"2024-10-08 21:36","pubTimestamp":1728394609,"startTime":"0","endTime":"0","summary":"智通财经APP讯,山河药辅(300452.SZ)公告,公司股东复星医药于2020年6月15日至2024年9月30日期间累计减持公司股份282.63万股,累计减持股份比例已达到公司总股本的1.29%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1191370.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0096","BK0175","BK0187","BK1515","BK0177","BK0060","BK0183","BK0188","BK1593","02196","BK1191","BK0196","300452","BK0028","BK0012","BK0239","600196"],"gpt_icon":0},{"id":"2462536311","title":"山河药辅(300452.SZ)发布上半年业绩,净利润9553.3万元,增长8.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462536311","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462536311?lang=zh_cn&edition=full","pubTime":"2024-08-27 16:57","pubTimestamp":1724749038,"startTime":"0","endTime":"0","summary":"智通财经APP讯,山河药辅(300452.SZ)发布2024年半年度报告,该公司营业收入为4.5亿元,同比减少0.67%。归属于上市公司股东的净利润为9553.3万元,同比增长8.16%。归属于上市公司股东的扣除非经常性损益的净利润为7992.15万元,同比减少2.33%。基本每股收益为0.41元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1171708.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300452"],"gpt_icon":0},{"id":"2462307001","title":"山河药辅最新公告:上半年净利润同比增长8.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462307001","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462307001?lang=zh_cn&edition=full","pubTime":"2024-08-27 16:37","pubTimestamp":1724747853,"startTime":"0","endTime":"0","summary":"山河药辅发布2024年半年度报告,公司上半年实现营业总收入4.5亿元,同比下降0.67%;归属于上市公司股东的净利润9553.3万元,同比增长8.16%。报告期内,公司替代进口业务稳定增长,外贸出口形势良好。研发创新能力持续提升,新增1项国家发明专利。产业化建设项目顺利投产,多个产品已顺利实现量产。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082700026912.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300452"],"gpt_icon":0},{"id":"2457639549","title":"山河药辅:公司定期报告和公司网站均有公司的联系方式和电话,欢迎洽谈合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2457639549","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457639549?lang=zh_cn&edition=full","pubTime":"2024-08-08 19:00","pubTimestamp":1723114859,"startTime":"0","endTime":"0","summary":"山河药辅董秘:投资者你好,截至2024年7月31日,公司已累计回购公司股份182.55万股,后续将结合市场情况继续实施回购, 回购的股份根据回购方案将用于后续员工持股计划或者股权激励。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080800037020.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0177","300452","BK0239"],"gpt_icon":0},{"id":"2457091715","title":"山河药辅最新公告:新增1种药用辅料产品聚维酮K25","url":"https://stock-news.laohu8.com/highlight/detail?id=2457091715","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457091715?lang=zh_cn&edition=full","pubTime":"2024-08-06 16:24","pubTimestamp":1722932694,"startTime":"0","endTime":"0","summary":"山河药辅公告,公司新增1种药用辅料产品:聚维酮K25获得国家药监局药品审评中心的登记号。聚维酮K25作为聚维酮系列产品,相比于聚维酮K30、K90等具有更小的分子量和更低的粘度,在制剂中的应用非常广泛。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080600031536.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0177","300452"],"gpt_icon":0},{"id":"2457993390","title":"【山河药辅(300452.SZ):聚维酮K25获CDE登记号】智通财经APP讯,山河药辅(300452.SZ)发布公告,近日公司新增1种药用辅料产品:聚维酮K25获得国家药品监督管理局药品审评中心(简称“CDE”)的登记号,为F20240000334。","url":"https://stock-news.laohu8.com/highlight/detail?id=2457993390","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457993390?lang=zh_cn&edition=full","pubTime":"2024-08-06 15:52","pubTimestamp":1722930778,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["300452","BK4017","CDE","BK0239","BK0177"],"gpt_icon":0},{"id":"2457960110","title":"山河药辅(300452.SZ):聚维酮K25获CDE登记号","url":"https://stock-news.laohu8.com/highlight/detail?id=2457960110","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457960110?lang=zh_cn&edition=full","pubTime":"2024-08-06 15:52","pubTimestamp":1722930778,"startTime":"0","endTime":"0","summary":"智通财经APP讯,山河药辅 发布公告,近日公司新增1种药用辅料产品:聚维酮K25获得国家药品监督管理局药品审评中心的登记号,为F20240000334。截止公告日,山河药辅已有45种产品获得CDE登记号。据悉,聚维酮K25作为聚维酮系列产品,相比于聚维酮K30、K90等具有更小的分子量和更低的粘度。许多难溶性药物与聚维酮混合后,能起到增加溶解度的效果。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1160483.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["CDE","BK4017","300452","BK0177","BK0239"],"gpt_icon":0},{"id":"2450356264","title":"山河药辅最新公告:公司新增1种药用辅料产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2450356264","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450356264?lang=zh_cn&edition=full","pubTime":"2024-07-11 19:51","pubTimestamp":1720698677,"startTime":"0","endTime":"0","summary":"山河药辅公告,近日公司新增1种药用辅料产品:粉状纤维素获得国家药品监督管理局药品审评中心(以下简称\"CDE\")的登记号。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071100038368.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300452","BK0239","BK0177"],"gpt_icon":0},{"id":"2448578199","title":"山河药辅(300452)7月1日主力资金净卖出610.28万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448578199","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448578199?lang=zh_cn&edition=full","pubTime":"2024-07-01 15:24","pubTimestamp":1719818661,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年7月1日收盘,山河药辅报收于11.06元,下跌2.64%,换手率2.48%,成交量4.64万手,成交额5109.86万元。近5日资金流向一览见下表:该股主要指标及行业内排名如下:山河药辅2024年一季报显示,公司主营收入2.38亿元,同比下降4.05%;归母净利润4981.51万元,同比上升0.86%;扣非净利润4224.06万元,同比下降7.56%;负债率37.57%,投资收益374.58万元,财务费用275.17万元,毛利率33.34%。山河药辅主营业务:药用辅料的研发、生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070100014211.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0177","300452","BK0239"],"gpt_icon":0},{"id":"2446389500","title":"山河药辅:复星医药拟减持1%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2446389500","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446389500?lang=zh_cn&edition=full","pubTime":"2024-06-28 21:09","pubTimestamp":1719580172,"startTime":"0","endTime":"0","summary":"山河药辅公告,持有公司11.20%股份的股东复星医药因经营需要,计划在2024年7月22日至2024年10月20日期间,通过集中竞价方式减持不超过232.6万股,占公司总股本的1%。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062800050883.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","BK1515","BK0096","600196","BK0175","BK0239","BK0028","BK0177","BK1593","300452","BK0060","02196","BK0183","BK0188","BK0012","BK0196","BK0187"],"gpt_icon":0},{"id":"2446507573","title":"山河药辅:复星医药拟减持1%公司股份山河药辅公告,持有公司11.20%股份的股东复星医药因经营需要,计划在2024年7月22日至2024年10月20日期间,通过集中竞价方式减持不超过232.","url":"https://stock-news.laohu8.com/highlight/detail?id=2446507573","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446507573?lang=zh_cn&edition=full","pubTime":"2024-06-28 21:04","pubTimestamp":1719579892,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1191","BK1515","300452","BK0012","BK0183","BK1593","BK0175","BK0188","BK0239","BK0177","600196","BK0196","BK0187","BK0028","02196","BK0060","BK0096"],"gpt_icon":0},{"id":"2446933539","title":"山河药辅:公司生产和经营现金流一直以来确实都比较好,每年的分红比例也较高","url":"https://stock-news.laohu8.com/highlight/detail?id=2446933539","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446933539?lang=zh_cn&edition=full","pubTime":"2024-06-27 20:00","pubTimestamp":1719489637,"startTime":"0","endTime":"0","summary":"谢谢山河药辅董秘:投资者你好,关于纳米微晶纤维素,公司有这方面的技术和生产设备,可以提供合格样品,客户如有需求,请联系公司进一步商谈,谢谢。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062700037561.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0177","300452"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2015-05-15","address":"安徽省淮南市大通区经济技术开发区河滨路2号","stockEarnings":[{"period":"1week","weight":-0.0651},{"period":"1month","weight":0.0088},{"period":"3month","weight":0.1671},{"period":"6month","weight":-0.0018},{"period":"1year","weight":-0.1675},{"period":"ytd","weight":-0.0951}],"companyName":"安徽山河药用辅料股份有限公司","boardCode":"AI0027","perCapita":"11888股","boardName":"医药制造业","registeredCapital":"23444万元","compareEarnings":[{"period":"1week","weight":-0.0222},{"period":"1month","weight":0.0259},{"period":"3month","weight":0.1713},{"period":"6month","weight":0.0737},{"period":"1year","weight":0.0905},{"period":"ytd","weight":0.1247}],"survey":" 安徽山河药用辅料股份有限公司的主营业务为药用辅料的研发、生产和销售。公司主要产品涵盖填充剂、黏合剂、崩解剂、润滑剂、包衣材料等常用口服固体制剂类药用辅料和注射级药用辅料等。其中:微晶纤维素、羟丙甲纤维素、低取代羟丙纤维素、羧甲淀粉钠、硬脂酸镁和薄膜包衣粉先后被评定为安徽省高新技术产品,“立崩”牌羧甲淀粉钠先后获得淮南市知名产品、安徽省名牌产品和“中国化学制药行业药用辅料优秀产品品牌”、首批“安徽工业精品”称号,羟丙甲纤维素荣获“中国化学制药行业优秀产品品牌”奖。微晶纤维素、硬脂酸镁和薄膜包衣粉产品被评定为淮南市知名产品,并有多个产品列入《中国高新技术产品出口目录》。公司多次获得“中国化学行业药用辅料优秀企业品牌”称号。","serverTime":1732101898611,"listedPrice":14.96,"stockholders":"15713人(较上一季度增加4.51%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"山河药辅(300452)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供山河药辅(300452)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"山河药辅,300452,山河药辅股票,山河药辅股票老虎,山河药辅股票老虎国际,山河药辅行情,山河药辅股票行情,山河药辅股价,山河药辅股市,山河药辅股票价格,山河药辅股票交易,山河药辅股票购买,山河药辅股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"山河药辅(300452)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供山河药辅(300452)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}